GEODE CAPITAL MANAGEMENT, LLC

Position in EDIT — Editas Medicine, Inc.

CIK 1214717 BOSTON, MA

Back to EDIT Full portfolio

Position in EDIT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,710,118

+$1,026,402 QoQ

Shares Held

2,311,789

+1.2% QoQ

Ownership

2.36%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. EDIT ranks #202 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

All Filings in EDIT

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,710,118	2,311,789	+1.2%	Shares	Defined	2026-05-15
2025-12-31	$4,683,716	2,284,740	+12.0%	Shares	Defined	2026-02-09
2025-09-30	$7,079,375	2,040,166	+3.9%	Shares	Defined	2025-11-12
2025-06-30	$4,321,454	1,964,298	+1.1%	Shares	Defined	2025-08-08
2025-03-31	$2,254,780	1,943,777	+7.5%	Shares	Defined	2025-05-13
2024-12-31	$2,296,874	1,808,563	-4.2%	Shares	Defined	2025-02-12
2024-09-30	$6,437,043	1,887,696	-4.0%	Shares	Defined	2024-11-12
2024-06-30	$9,180,388	1,965,822	+1.1%	Shares	Defined	2024-08-09
2024-03-31	$14,430,141	1,944,763	+2.3%	Shares	Defined	2024-05-13
2023-12-31	$19,264,575	1,901,735	+5.2%	Shares	Defined	2024-02-13
2023-09-30	$14,102,236	1,807,979	+21.1%	Shares	Defined	2023-11-13
2023-06-30	$12,285,933	1,492,823	+2.9%	Shares	Defined	2023-08-11
2023-03-31	$10,521,591	1,451,254	+5.2%	Shares	Defined	2023-05-15
2022-12-31	$12,237,788	1,379,683	+9.8%	Shares	Defined	2023-02-13
2022-09-30	$15,379,804	1,256,520	+2.4%	Shares	Defined	2022-11-14
2022-06-30	$14,511,032	1,226,630	+7.9%	Shares	Defined	2022-08-12
2022-03-31	$21,613,300	1,136,346	-6.9%	Shares	Defined	2022-05-13
2021-12-31	$32,400,850	1,220,371	+2.1%	Shares	Defined	2022-02-11
2021-09-30	$49,094,215	1,195,088	-0.8%	Shares	Defined	2021-11-12
2021-06-30	$68,266,549	1,205,271	+4.5%	Shares	Defined	2021-08-13
2021-03-31	$48,441,330	1,153,365	+19.5%	Shares	Defined	2021-05-12
2020-12-31	$67,668,279	965,173	+3.6%	Shares	Defined	2021-02-12
2020-09-30	$26,129,247	931,192	+4.7%	Shares	Defined	2020-11-13
2020-06-30	$26,316,704	889,679	+13.4%	Shares	Defined	2020-08-13
2020-03-31	$15,557,983	784,568	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.